# Janus Henderson Investors

> Janus Henderson Investors co-led Star Therapeutics' $200M private financing announced on October 23, 2026, alongside OrbiMed. Vish Sridharan, assistant portfolio manager and research analyst, is joining Star as a board observer. In Star's announcement, Sridharan said the firm does not often invest at this development stage and emphasized the team's ability to identify therapeutic opportunities and develop medicines. The announcement did not disclose Janus Henderson's individual allocation or a Star valuation. This participation should not be interpreted as an independently validated clinical outcome.

## Profile

- **Stage-based planning range:** $100K–$1M
- **Check-size evidence basis:** estimated
- **Founded:** N/A
- **Headquarters:** N/A
- **AUM:** N/A
- **Rounds they lead:** N/A
- **Rounds they invest:** N/A
- **Last verified:** 2026-10-24

## Links

- [Website](https://www.janushenderson.com/)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 24, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/fund/janus-henderson-investors